Why the study?
Non-invasive echocardiographic quantification of cardiac rotation cannot continuously monitor patient status, and pressure-sensor-based HF monitoring systems face potential reliability issues.
Is the CardioMon lead accurate and reliable in detecting cardiac twisting velocities in vitro?
Is the CardioMon lead accurate and reliable in detecting cardiac twisting velocities in vitro?
A novel implantable lead with a 3D gyroscope for continuous monitoring of cardiac apex rotation demonstrated accuracy in vitro, offering a potential future tool for heart failure monitoring.
Answers are grounded in this paper and cite their sources.
In vitro accuracy supports preclinical lead development; leaves open in vivo validation for heart failure monitoring.
Changes in the pattern or amplitude of cardiac rotation have been associated with important cardiovascular diseases, including Heart Failure (HF) which is one of the major health problems worldwide. Recent advances in echocardiographic techniques have allowed for non-invasive quantification of cardiac rotation; however, these examinations do not address the continuous monitoring of patient status. We have presented a newly developed implantable, transvenous lead with a tri-axis (3D) MEMS gyroscope incorporated near its tip to measure cardiac apex rotation in the three-dimensional space. We have named it CardioMon for its intended use for cardiac monitoring. If compared with currently proposed implantable systems for HF monitoring based on the use of pressure sensors that can have reliability issues, an implantable motion sensor like a gyroscope holds the premise for more reliable long term monitoring. The first prototypal assembly of the CardioMon lead has been tested to assess the reliability of the 3D gyroscope readings. In vitro results showed that the novel sensorized CardioMon lead was accurate and reliable in detecting angular velocities within the range of cardiac twisting velocities. Animal experiments will be planned to further evaluate the CardioMon lead in in vivo environments and to investigate possible endocardial implantation sites.
No takes yet. Share an insight, caveat, or question.
Marcelli et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: